ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2742

Polymorphisms in the Slam Family of Molecules Play a Role in the Development and Function of Invariant Natural Killer T Cells in New Zealand Black Mice

Yuriy Baglaenko1, Kieran Manion1, Nan-Hua Chang2 and Joan E. Wither3, 1Immunology, University of Toronto, Toronto, ON, Canada, 2Genetics and Development, Toronto Western Research Institute, Toronto Western Hospital, Toronto, ON, Canada, 31E420/Div of Rheumatology, Toronto Western Research Institute, Toronto Western Hospital, University of Toronto, Toronto, ON, Canada

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: genetics and mouse model, T cells

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: T cell Biology in Lupus, Vasculitis, Myositis and Other Autoimmunity

Session Type: Abstract Submissions (ACR)

Background/Purpose: The family of signaling lymphocyte activating molecules (SLAM) have been shown to play a key role in the development of autoimmunity in spontaneous and induced mouse models. Previous work by others has shown that expression of two SLAM family members, CD150 and Ly108, plays a critical role in the development of Natural Killer T (NKT) cells, an innate-like semi-invariant population of lymphocytes, which quickly respond to lipids presented on non-classical MHCs. However, the impact of SLAM polymorphisms on NKT function is less clear. The aim of this study was to characterize both the development and function of NKT cells in B6 congenic mice with an NZB chromosome 1 interval that is known to have polymorphisms in the SLAM family of molecules. 

Methods:  NKT development and marker expression were examined by flow cytometry of de novo splenocytes and thymocytes. NKT cell function was examined by in vivo stimulation with 2µg of αGalCer, injected intravenously. Production of IFNγ and IL-4 was measured by intracellular flow cytometry. Bone marrow derived dendritic cells (BMDCs) were generated by 7-10 day culture with recombinant human FLT3 ligand.

Results:  Congenic mice had significantly fewer splenic NKT cells when compared to B6 controls.  However, NKT cell frequencies in the thymus did not differ. The frequency of double positive thymocytes, critical for homotypic interactions between NKT cell precursors, was also unchanged.  In support of previous findings, cell surface expression of SLAM family members on this cell population was altered. When compared to control animals, NZB congenic mice had significantly decreased expression of positive signaling Ly108 and CD150 molecules and increased expression of the negative SLAM signaling molecule, Ly9. Since NKT cells have been shown to play a role in autoimmunity through production of cytokines such as IL-4 and IFNγ, the capacity of these cells to secrete cytokines was assessed. Upon stimulation with αGalCer, the prototypic NKT cell stimulating lipid, NKT cells from NZB congenic mice produced significantly less IL-4 and IFNγ when compared to control mice.  Consistent with this being the result of the SLAM polymorphisms, analysis of subcongenic NZB strains with shorter chromosome 1 intervals revealed that both of these phenotypes localized to a small region between 171-177Mb containing the SLAM family. To determine whether the reduced NKT cytokine production in NZB congenic mice was due to altered antigen presentation or impaired NKT cell function, adoptive transfer experiments were conducted with αGalCer pulsed BMDCs from control or congenic mice. The results revealed that injection of BMDCs generated from either strain could equivalently stimulate IL- 4 and IFNγ production by NKT cells in control animals, whereas injection of control BMDCs into NZB congenic mice resulted in impaired production of these cytokines.

Conclusion: These data suggest that polymorphisms in the SLAM family result in reduced peripheral NKT cell numbers and an intrinsic NKT cell functional defect.


Disclosure:

Y. Baglaenko,
None;

K. Manion,
None;

N. H. Chang,
None;

J. E. Wither,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/polymorphisms-in-the-slam-family-of-molecules-play-a-role-in-the-development-and-function-of-invariant-natural-killer-t-cells-in-new-zealand-black-mice/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology